Literature DB >> 23104749

Anticipated changes in sexual risk behaviour following vaccination with a low-efficacy HIV vaccine: survey results from a South African township.

K M Andersson1, E Vardas, L M Niccolai, R M Van Niekerk, M M Mogale, I M Holdsworth, M Bogoshi, J A McIntyre, G E Gray.   

Abstract

We assessed the potential for anticipated changes in sexual risk-taking behaviour following hypothetical administration of a low-efficacy preventive HIV vaccine. We developed a survey and collected self-reported data from 158 HIV-negative volunteers in a cohort undergoing prescreening for Phase I/II HIV vaccine trials in Soweto. Overall, 22% reported they might use condoms less frequently; 9% reported that they might increase their frequency of sex with casual/anonymous partners; and 55% reported their sexual partners might want to use condoms less frequently knowing they were vaccinated. Multivariate analyses revealed that anticipated decrease in condom use was predicted by poor comprehension and by young age. Individuals may increase their risk-taking behaviour knowing that a vaccine would provide only incomplete protection against HIV transmission. In HIV vaccine trials and future vaccination programmes, education and risk-reduction counselling will be needed for vaccinated individuals and their partners, and mass media education campaigns may be necessary.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23104749      PMCID: PMC3699204          DOI: 10.1258/ijsa.2009.009378

Source DB:  PubMed          Journal:  Int J STD AIDS        ISSN: 0956-4624            Impact factor:   1.359


  29 in total

1.  Sexual risk behaviour of Canadian participants in the first efficacy trial of a preventive HIV-1 vaccine.

Authors:  Thomas M Lampinen; Keith Chan; Robert S Remis; Maraki Fikre Merid; Melanie Rusch; Jean Vincelette; Ken Logue; Vladimir Popovic; Michel Alary; Martin T Schechter; Robert S Hogg
Journal:  CMAJ       Date:  2005-02-15       Impact factor: 8.262

2.  Randomized controlled trial of audio computer-assisted self-interviewing: utility and acceptability in longitudinal studies. HIVNET Vaccine Preparedness Study Protocol Team.

Authors:  D S Metzger; B Koblin; C Turner; H Navaline; F Valenti; S Holte; M Gross; A Sheon; H Miller; P Cooley; G R Seage
Journal:  Am J Epidemiol       Date:  2000-07-15       Impact factor: 4.897

Review 3.  Challenges for HIV vaccine dissemination and clinical trial recruitment: if we build it, will they come?

Authors:  Peter A Newman; Naihua Duan; Ellen T Rudy; Peter A Anton
Journal:  AIDS Patient Care STDS       Date:  2004-12       Impact factor: 5.078

4.  HIV sexual risk behavior over 36 months of follow-up in the world's first HIV vaccine efficacy trial.

Authors:  Bradford N Bartholow; Susan Buchbinder; Connie Celum; Vamshidar Goli; Beryl Koblin; Michael Para; Michael Marmor; Richard M Novak; Kenneth Mayer; Catherine Creticos; Patti Orozco-Cronin; Vladimir Popovic; Timothy D Mastro
Journal:  J Acquir Immune Defic Syndr       Date:  2005-05-01       Impact factor: 3.731

5.  Motivations for participating in an HIV vaccine efficacy trial.

Authors:  Grant Colfax; Susan Buchbinder; Goli Vamshidar; Connie Celum; David McKirnan; Judith Neidig; Beryl Koblin; Marc Gurwith; Brad Bartholow
Journal:  J Acquir Immune Defic Syndr       Date:  2005-07-01       Impact factor: 3.731

6.  Determinants of personal demand for an AIDS vaccine in Uganda: contingent valuation survey.

Authors:  David Bishai; George Pariyo; Martha Ainsworth; Kenneth Hill
Journal:  Bull World Health Organ       Date:  2004-09       Impact factor: 9.408

7.  Sexual risk behaviour of the first cohort undergoing screening for enrollment into Phase I/II HIV vaccine trials in South Africa.

Authors:  K M Andersson; R M Van Niekerk; L M Niccolai; O N Mlungwana; I M Holdsworth; M Bogoshi; J A McIntyre; G E Gray; E Vardas
Journal:  Int J STD AIDS       Date:  2009-02       Impact factor: 1.359

8.  Perceived influence of an HIV vaccine on sexual-risk behaviour in the Dominican Republic.

Authors:  Clare Barrington; Luis Moreno; Deanna Kerrigan
Journal:  Cult Health Sex       Date:  2008-05

9.  Will sexual risk behaviour increase after being vaccinated for AIDS?

Authors:  Richard A Crosby; David R Holtgrave
Journal:  Int J STD AIDS       Date:  2006-03       Impact factor: 1.359

10.  Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: the ANRS 1265 Trial.

Authors:  Bertran Auvert; Dirk Taljaard; Emmanuel Lagarde; Joëlle Sobngwi-Tambekou; Rémi Sitta; Adrian Puren
Journal:  PLoS Med       Date:  2005-10-25       Impact factor: 11.069

View more
  3 in total

1.  A comparison of sexual risk behaviours and HIV seroprevalence among circumcised and uncircumcised men before and after implementation of the safe male circumcision programme in Uganda.

Authors:  Simon Peter Sebina Kibira; Ingvild Fossgard Sandøy; Marguerite Daniel; Lynn Muhimbuura Atuyambe; Fredrick Edward Makumbi
Journal:  BMC Public Health       Date:  2016-01-05       Impact factor: 3.295

2.  Projected economic evaluation of the national implementation of a hypothetical HIV vaccination program among adolescents in South Africa, 2012.

Authors:  Nishila Moodley; Glenda Gray; Melanie Bertram
Journal:  BMC Public Health       Date:  2016-04-14       Impact factor: 3.295

3.  Sexual Behaviours and Practices before and after Phase I/II HIV Vaccine Trial: A Qualitative Study among Volunteers in Dar es Salaam Tanzania.

Authors:  Masunga K Iseselo; Edith A M Tarimo; Eric Sandstrom; Asli Kulane
Journal:  Int J Environ Res Public Health       Date:  2020-10-01       Impact factor: 3.390

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.